primary hypercholesterolaemia and mixed dyslipidemia
Showing 1 - 1 of 1
Primary Hypercholesterolaemia and Mixed Dyslipidemia Trial in Beijing (JS002, Placebo)
Not yet recruiting
- Primary Hypercholesterolaemia and Mixed Dyslipidemia
- JS002
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Nov 17, 2022